COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Departmental Seminar Programme, Department of Veterinary Medicine > Computational Methods to Design Broad-Spectrum Medical Countermeasures Against Antigenically Diverse Pathogens
Computational Methods to Design Broad-Spectrum Medical Countermeasures Against Antigenically Diverse PathogensAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Fiona Roby. Abstract Antigenically diverse pathogens, such as coronaviruses, highlight the need for broad-spectrum vaccines that protect against a range of variants. In this talk, I will introduce Spectravax, a computational framework for designing vaccines optimised for genetic diversity in both hosts and pathogens. Using Spectravax, I designed a nucleocapsid antigen that elicited immune responses to SARS -CoV-1, SARS -CoV-2, and MERS -CoV—the three coronaviruses responsible for major outbreaks since 2002. Bio Phil recently submitted his PhD thesis, which he completed in Prof. Jonathan Heeney’s lab, focusing on computational methods to design broad-spectrum vaccines and antibodies. He previously worked as a bioinformatician in industry, was a visiting researcher at MIT , and completed his undergraduate degree in Biology at the University of Southampton. This talk is part of the Departmental Seminar Programme, Department of Veterinary Medicine series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsCamtessential Exoplanet Seminars Type the title of a new list hereOther talksResults of beamline testing at the MROI Save the date. Details of this seminar will follow shortly. Save the date. Details of this seminar will follow shortly. Is the bacterial accessory genome adaptive? The economic transformation of Iron Age Britain under Roman colonisation, with a special focus on Cambridgeshire Seth Coffelt, Professor of Cancer Immunology, University of Glasgow |